Soluzioni per Dialisi Peritoneale: Sono Biocompatibili?

Dobbie J.W. , Zaki M.A. . The ultrastructure of parietal peritoneum in normal and uremic man and in patients on CAPD. In: Maher J.F. , Winchester J.F. , eds. Frontiers in peritoneal dialysis. Field, Rich and Associates, New York 1986; 3–10.

Di Paolo N. . The morphology of peritoneal membrane during peritoneal dialysis. In: Greca La , eds. Peritoneal Dialysis. Wichtig Editore, Milano 1988; 3–6.

Grahame G.R. , Torchia M.G. , Dankewich K.A. , Ferguson I.A. . Peritoneal surface-active material in peritoneal effluent of CAPD patients. Perit Dial Bull 1985; 5: 109–11.

Di Paolo N. , Buoncristiani U. , Capotondo L. Phosphatidylcholine and peritoneal transport during peritoneal dialysis. Nephron 1986; 44: 365–70.

Degl'Innocenti M.L. , Valle M. , Bertelli R. Le cellule me-soteliali del peritoneo umano: fenotipo e presentazione dell'antigene. In: Passione A. , eds. Dialisi Peritoneale. Wichtig Editore, Milano 1991; 495–500.

Verbrugh H.A. , Keane W.F. , Conroy W.E. , Peterson P.K. . Bacterial growth and killing in chronic ambulatory peritoneal dialysis. J Clin Microbiol 1984; 20: 1299–303.

Carozzi S. . Biocompatibility and CAPD. Attualità Nefrologiche e Dialitiche, 1990. Wichtig Editore, Milano 1991; 101–10.

Carozzi S. . Cytokine disorders in CAPD. In: La Greca G. , eds. Peritoneal Dialysis. Wichtig Editore, Milano 1991; 171–8.

Carozzi S. , Nasini M.G. , Caviglia P.M. , Schelotto C. , Canta-luppi A. , Salit M. . Effetti in vivo del Ca ^{+ +} e dell’ 1,25 (OH) 2D3 sull'attività battericida dei macrofagi peritoneali in CAPD. In: Di Paolo N. , Gaggiotti E. , eds. Nefrologia, Dialisi, Trapianto 1990. Wichtig Editore, Milano 1990; 851–4.

Rottembourg J. , Brouard R. , Is-sad B. , Allouache M. , Ghali B. , Boudjemaa A. . Role of acetate in loss of ultrafiltration during CAPD. Contributions to Nephrology 1987; 57: 197–206.

Shaldon S. , Dinarello C.A. , Wyler D.J. . Induction of Interleu-kin-1 during CAPD. Contributions to Nephrology 1987; 57: 207–12.

Mackow R.C. , Winchester J.F. , Argy W.P. Sclerosing encapsulating peritonitis in rats: an experimental study with intraperitoneal antiseptics. Contributions to Nephrology 1987; 57: 213–8.

Lo Wai-Ke , Chan Kwok-Tat , Leung A.C.T. , Pang Siu-Wah , Tse Chun-Yan . Sclerosing peritonitis complicating prolonged use of chlorexidine in alcohol in the connection procedure for continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 11: 166–72.

Catizone L. , Cocchi R. , Fusaro-li M. , Zucchelli P. . Studio del comportamento della Beta 2-microglobulina in CAPD: confronto con l'emodialisi. In: Passione A. , eds. Dialisi Peritoneale. Wichtig Editore, Milano 1991; 489–94.

Maiorca R. . Cancarini GC, Camerini C, et al. Is CAPD competitive with hemodialysis for long-term treatment of uraemic patients? Nephrol Dial Transplant 1989; 4: 244–53.

Scalamogna A. , Imbasciati E. , De Vecchi A. Beta-2 microglobulin in patients on peritoneal dialysis and hemodialysis. Perit Dial Int 1989; 9: 37–40.

Manili L. , Mombelloni S. , Camerini C. Amiloidosi uremica: uguale incidenza in dialisi extracorporea ed in dialisi peritoneale ambulatoriale continua. In: Passione A. , eds. Dialisi Peritoneale. Wichtig Editore, Milano 1991; 545–7.